Serious neurologic adverse events in Tofersen clinical trials for amyotrophic lateral sclerosis

Lovett, A., Chary, S., Babu, S. et al. (15 more authors) (2025) Serious neurologic adverse events in Tofersen clinical trials for amyotrophic lateral sclerosis. Muscle & Nerve. ISSN 0148-639X

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Lovett, A.
  • Chary, S.
  • Babu, S.
  • Bruneteau, G.
  • Glass, J.D.
  • Karlsborg, M.
  • Ladha, S.
  • Mayl, K.
  • McDermott, C. ORCID logo https://orcid.org/0000-0002-1269-9053
  • Bucelli, R.C.
  • Chiò, A.
  • Ferguson, T.A.
  • Cochrane, T.
  • Fradette, S.
  • Smirnakis, K.
  • Inra, J.
  • Malek, S.
  • Fanning, L.
Copyright, Publisher and Additional Information:

© 2025 The Author(s). Muscle & Nerve published by Wiley Periodicals LLC. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Keywords: SOD1‐ALS; VALOR; myelitis; serious adverse events; tofersen
Dates:
  • Published: 27 February 2025
  • Published (online): 27 February 2025
  • Accepted: 28 January 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 26 Mar 2025 17:00
Last Modified: 26 Mar 2025 17:00
Status: Published online
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1002/mus.28372
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics